(Date:10/13/2008)...cessation programs, along with referrals to cardia...reased rates of quitting smoking following heart a... issue of Archives of Internal Medicine, one of ...esearchers studied 639 patients who smoked at the ...x months later, 297 of the patients approximately...
(Date:10/13/2008)...RM THIS WINTER WITH THE VIPER RESPONDER LE SPECIAL...RT SYSTEM, VISTA, Calif., Oct. 13 /PRNewswire-Fir...bsidiary of DEI Holdings Inc. (Nasdaq: DEIX ), ha...availability of Responder LE,Special Edition 2-Way...r,supporting Susan G. Komen for the Cure. For eac...
(Date:10/13/2008)...were lower than Alzheimer,s patients, healthy cont...ws) -- Parkinson,s disease patients are more likel...ave vitamin D deficiency, say researchers from the..., They compared vitamin D levels in 100 Parkinso...thy people matched for age and other factors. ,...
(Date:10/13/2008)...ion dollar NIH funding advances study Study ...s, MINNEAPOLIS, Oct. 13 /PRNewswire/ -- Advanced ...culatory.com ) announced today that it has receive...ational Institutes of,Health (NIH) to continue a s...ose who experience cardiac arrest outside a hospit...
Breaking Medicine News(10 mins):Health News:Supporting Susan G. Komen for the Cure(R) During National Breast Cancer Awareness Month 2Health News:Supporting Susan G. Komen for the Cure(R) During National Breast Cancer Awareness Month 3Health News:Parkinson's Patients More Prone to Vitamin D Deficiency 2Health News:3 Michigan Counties Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 2...ers have successfully cured advanced melanoma skin...ells causing them to attack the cancer cells. // A...ute (NCI) have confirmed in their research that ar...t advanced melanoma, which is considered as the mo...
...al Research Council suggests that cancers like cer...the presence of a hormone in semen.// The research... the development of tumors. In a report in the Jou...uction, the researchers recommend that women havin...
... potential of growing by a whopping 25 percent ann...) a year by 2012, Tourism Minister Ambika Soni sai...d looking at the response from foreign patients, w...Rs.100 billion annually by 2012," said Soni while ...
...sumed lending to India's health sector with an app...rnment said Tuesday.// "Three projects totalling $...ar, have now been approved by the board of executi...ank," a finance ministry statement said. The appr...
Other Medicine News:Health News:Gene Therapy Used In Treating Cancer 2Health News:Medical Tourism can Fetch Rs.100 bn Annually by 2012 2Health News:Medical Tourism can Fetch Rs.100 bn Annually by 2012 3(Date:10/12/2008)...N, Oct. 12 /- Boston,Scient...ults from an analysis,of nearly 7,500 patients fro...esigned to confirm the performance of the TAXUS(R)...stem in real-world practice. The,two-year pooled A...nical,restenosis in patients with diabetes as effe...
(Date:10/10/2008)...Newswire-FirstCall/ -- Inverness Medical,Innovatio...-patient,diagnostics, monitoring and health manage...e Secretary-General of the United Nations, as part...he world,s leading,research-based and generic phar...gether with senior officials from the United Natio...
(Date:10/9/2008)...s on the need to protect the eyesight of,older peo...illion people worldwide who,are blind, 80 percent ...have avoided their blindness if they had been prop...a News Release, go to:, http://www.prnewswire.com/...ye care products and equipment, is,partnering with...
(Date:10/9/2008)...swire-FirstCall/ -- Diamyd Medical reports,that th...w England Journal,of Medicine, has published an ar... Diamyd(R) diabetes vaccine for type 1 diabetes., ...314/297194 ), The article is now available on th...ill be in print on October 30. It presents the,res...
Breaking Medicine Technology:TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 3ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Alzheimers Treatment Trials May Have Special Challenges 24437 1Alzheimers Treatment Trials May Have Special Challenges 24437 2David Farhadi M D to Join Alger as Vice President Senior Analyst Co Portfolio Manager 6754 1David Farhadi M D to Join Alger as Vice President Senior Analyst Co Portfolio Manager 6754 2The kids most likely to go armed 24429 1The kids most likely to go armed 24429 2Pre eclampsia may be autoimmune disease 4220 1Pre eclampsia may be autoimmune disease 4220 2Pre eclampsia may be autoimmune disease 4220 3...ire-FirstCall/ -- Celgene,Corporation announced th...as reported that its Data Monitoring Committee,s (...andomized clinical,trial for patients with newly d...f a low dose of dexamethasone (Decadron) in,combin...e for,patients when compared to the higher, standa...
...ire/ -- Novagali Pharma, an,emerging ophthalmic ph... announces today positive results from the Phase I...ing from Vernal,Keratoconjunctivitis (VKC). In thi...and signs of disease improved in patients,receivin...acia(R),was excellent. , VKC is a severe form of c...
Other Medicine Technology:ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 2ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 3ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 4ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 5ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 6ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 7Novagali Pharma Announces Positive Vekacia Clinical Results From,Pivotal Phase III Trial in Vernal Keratoconjunctivitis 2...lXpress kit provides a rapid method for the ...tent nucleic acids; however, the kit does not sepa...NA can be achieved by incubating the purified mate...lowed by re-extraction with ViralXpress. The...
The Mago® Plus Automated EIA Analyzer is a fully automated, integrated ELISA system. Together, with immunosimplicity® reagents, the Mago® Plus provides a flexible, integrated solution
The Titertek MAP-C2 is designed for high throughput microplate processing. The heart of the instrument is the S60 Stacker that handles up to 60 microplates in two removable magazines. The MAP-C2 base
...imeter 4000 provides a fast, accurate assessment o...eters patented,state-of-the-art optics yield acc...moglobin as well as total hemoglobin. When,used ...imeter,4000 gives a comprehensive and complete a...
Medicine Products: